» Articles » PMID: 39736988

The Changes of Intestinal Flora and Metabolites in Atopic Dermatitis Mice

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 Dec 31
PMID 39736988
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Atopic dermatitis (AD) is an allergic disease caused by various factors that can affect an individual's appearance and cause psychological stress. Therefore, it is necessary to investigate the underlying mechanisms and develop effective treatment strategies. The gut microbiota and bacterial metabolism play crucial roles in human diseases. However, their specific role in AD remains unclear.

Methods: In this study, we established a mouse model of AD and found that 2,4-dinitrofluorobenzene disrupted the skin barrier in mice. The species composition of intestinal bacteria was then analyzed by fecal 16s rRNA sequencing. The metabolic level of mice was analyzed by untargeted and targeted metabolomics in stool.

Results: The levels of filaggrin and aquaporin 3 proteins in the model mice and total superoxide dismutase, catalase and malondialdehyde levels were significantly altered. Additionally, inflammatory factors such as tumor necrosis factor-alpha showed a significant increase. Using 16S rRNA gene sequencing, we identified 270 bacterial species with altered abundances of and . The untargeted metabolomic analysis detected 1,299 metabolites. Targeted analysis of free fatty acids revealed 49 metabolites with notable increases in linoleic and linolenic acid levels. Fecal bacterial transplantation experiments have demonstrated that oxidative stress, inflammation, and skin barrier damage were alleviated after transplantation.

Discussion: These findings suggested that the metabolite linoleic acid negatively correlated with and may influence AD development. Perturbations in the intestinal bacteria and flora contributed to the development of AD, and the mouse model could serve as a valuable tool for further investigation of therapeutic approaches for managing ADS.

References
1.
Gao T, Wang X, Li Y, Ren F . The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review. Nutrients. 2023; 15(14). PMC: 10385652. DOI: 10.3390/nu15143123. View

2.
Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G . Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front Immunol. 2020; 11:575. PMC: 7147503. DOI: 10.3389/fimmu.2020.00575. View

3.
Fang Z, Li L, Zhang H, Zhao J, Lu W, Chen W . Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review. Front Immunol. 2021; 12:720393. PMC: 8317022. DOI: 10.3389/fimmu.2021.720393. View

4.
Pabst O, Hornef M, Schaap F, Cerovic V, Clavel T, Bruns T . Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023; 20(7):447-461. DOI: 10.1038/s41575-023-00771-6. View

5.
Stec A, Sikora M, Maciejewska M, Paralusz-Stec K, Michalska M, Sikorska E . Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases. Int J Mol Sci. 2023; 24(4). PMC: 9961773. DOI: 10.3390/ijms24043494. View